Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians

Ramachandran Rajalakshmi1, Ganesan UmaSankari1, Sobha Sivaprasad2

  • 1Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, India.

Insights

Diabetic retinopathy (DR) affects 6% of Asian Indians with prediabetes. Higher HbA1c levels in prediabetes significantly increase DR risk, highlighting the need for early glycemic control.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Public Health

Background:

  • Prediabetes is a growing concern globally, particularly in Asian Indian populations.
  • Diabetic retinopathy (DR) is a major microvascular complication of diabetes.
  • The prevalence and risk factors of DR in prediabetes are not well-established in this demographic.

Purpose of the Study:

  • To determine the prevalence of diabetic retinopathy (DR) in Asian Indians diagnosed with prediabetes.
  • To identify systemic risk factors associated with DR in this prediabetic population.

Main Methods:

  • A cross-sectional study involving 192 individuals with prediabetes (defined by OGTT/HbA1c 5.7%-6.4%) was conducted.
  • Clinical, biochemical assessments, and nonmydriatic ultra-wide field fundus photography were performed.
  • Retinal images were graded by certified ophthalmologists, and risk factors were analyzed.

Main Results:

  • Diabetic retinopathy (DR) was identified in 6.3% of individuals with prediabetes (mild NPDR in 4.7%, moderate NPDR in 1.6%).
  • No severe or sight-threatening DR was observed.
  • Higher HbA1c levels (≥6%) were significantly associated with a 2-fold increased relative risk of DR (RR 1.95, p=0.028) after adjusting for covariates.

Conclusions:

  • Approximately 6% of Asian Indians with prediabetes exhibit diabetic retinopathy.
  • Elevated HbA1c levels in the prediabetic stage are a significant risk factor for DR.
  • Emphasizing robust glycemic control before diabetes diagnosis is crucial to prevent DR.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
935
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
252
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
428